MLICM
EYE icon

Metropolitan Life Insurance Company (MetLife)’s National Vision EYE Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio EYE Stock Details EYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,129
Closed -$91.5K – 729
2024
Q1 		$91.5K Sell
4,129
-629
-13% -$13.3K ﹤0.01% 1094
2023
Q4 		$99.6K Hold
4,758
– – ﹤0.01% 1080
2023
Q3 		$77K Buy
4,758
+402
+9% +$8.04K ﹤0.01% 1163
2023
Q2 		$106K Hold
4,356
– – 0.01% 995
2023
Q1 		$82.1K Sell
4,356
-497
-10% -$16.2K ﹤0.01% 1105
2022
Q4 		$188K Buy
4,853
+114
+2% +$4.27K 0.01% 743
2022
Q3 		$155K Sell
4,739
-424
-8% -$13.8K 0.01% 776
2022
Q2 		$142K Hold
5,163
– – 0.01% 872
2022
Q1 		$225K Sell
5,163
-16,152
-76% -$655K 0.01% 764
2021
Q4 		$1.02M Hold
21,315
– – 0.01% 945
2021
Q3 		$1.21M Sell
21,315
-783
-4% -$43.3K 0.02% 821
2021
Q2 		$1.13M Buy
22,098
+79
+0.4% +$3.88K 0.02% 919
2021
Q1 		$965K Sell
22,019
-740
-3% -$35.3K 0.01% 950
2020
Q4 		$1.03M Sell
22,759
-131
-0.6% -$5.7K 0.02% 858
2020
Q3 		$875K Sell
22,890
-1,574
-6% -$54.7K 0.01% 822
2020
Q2 		$747K Buy
24,464
+1,124
+5% +$29.5K 0.01% 923
2020
Q1 		$453K Sell
23,340
-1,110
-5% -$34.6K 0.01% 1098
2019
Q4 		$793K Sell
24,450
-530
-2% -$14.6K 0.01% 1041
2019
Q3 		$601K Buy
24,980
+4,693
+23% +$137K 0.01% 1182
2019
Q2 		$623K Buy
20,287
+473
+2% +$13.6K 0.01% 1166
2019
Q1 		$623K Sell
19,814
-476
-2% -$15K 0.01% 1158
2018
Q4 		$572K Buy
20,290
+4,513
+29% +$172K 0.01% 1109
2018
Q3 		$712K Buy
+15,777
New +$665K 0.01% 1123
2018
Q2 		– Sell
-9,873
Closed -$319K – 2468
2018
Q1 		$319K Buy
9,873
+773
+8% +$28.2K ﹤0.01% 1572
2017
Q4 		$370K Buy
+9,100
New +$299K ﹤0.01% 1483

Other funds holding EYE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s EYE Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of National Vision (EYE) in Q2 2024, closing a stake of 4,129 shares — an estimated $91.5K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in EYE in Q4 2017 and held it in 25 quarters. The position peaked at $1.21M in Q3 2021. 187 funds tracked by Wall St. Rank hold EYE as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining National Vision position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 4,129 National Vision shares in Q2 2024, an estimated $91.5K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in National Vision in Q4 2017 and held it in 25 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s National Vision position peaked at $1.21M in Q3 2021.
  • 187 funds tracked by Wall St. Rank held National Vision as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.